RNAC
Cartesian Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.57 / 10
Underperform
The technical score of 1.57/10 conveys challenging technical structure. Strengths identified in no significant factors are compromised by deficiencies in Inverted Hammer, Long Lower Shadow, Marubozu White, and Long Upper Shadow. Technical interpretation: cautious.
Analysis Checks(0/4)
Long Lower Shadow
Score2.4/10
Win Rate45.10%
Hist. Signals51
Avg Return0.27%
Score2.4/10
Win Rate45.10%
Hist. Signals51
Avg Return0.27%
Inverted Hammer
Score1.89/10
Win Rate40.00%
Hist. Signals5
Avg Return-0.88%
Score1.89/10
Win Rate40.00%
Hist. Signals5
Avg Return-0.88%
Long Upper Shadow
Score1/10
Win Rate33.96%
Hist. Signals53
Avg Return-0.05%
Score1/10
Win Rate33.96%
Hist. Signals53
Avg Return-0.05%
Marubozu White
Score1/10
Win Rate33.33%
Hist. Signals18
Avg Return-2.99%
Score1/10
Win Rate33.33%
Hist. Signals18
Avg Return-2.99%
Long Lower Shadow
Score2.4/10
Win Rate45.10%
Hist. Signals51
Avg Return0.27%
Score2.4/10
Win Rate45.10%
Hist. Signals51
Avg Return0.27%
Long Upper Shadow
Score1/10
Win Rate33.96%
Hist. Signals53
Avg Return-0.05%
Score1/10
Win Rate33.96%
Hist. Signals53
Avg Return-0.05%
Inverted Hammer
Score1.89/10
Win Rate40.00%
Hist. Signals5
Avg Return-0.88%
Score1.89/10
Win Rate40.00%
Hist. Signals5
Avg Return-0.88%
Marubozu White
Score1/10
Win Rate33.33%
Hist. Signals18
Avg Return-2.99%
Score1/10
Win Rate33.33%
Hist. Signals18
Avg Return-2.99%
What is the current technical signals for RNAC?
- RNAC presents a Underperform setup with a Technical Score of 1.57/10. Key technical indicators highlight an RSI of 42.91 and a MACD of -0.08, with the trend anchored by the 50-Day SMA at 6.98. Traders should monitor key support at 6.16 and resistance at 6.36.
